Pharmaceutical composition for treating type 2 diabetes mellitus and preparation method of pharmaceutical composition
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for type 2 diabetes and composition, applied in the directions of drug combination, pharmaceutical formula, active ingredient of hydroxyl compound, etc., to avoid subcutaneous fat accumulation, eliminate side effects, and promote digestion
Inactive Publication Date: 2020-11-20
陈爱红
View PDF2 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0008] At present, the combination of triptolide, triptolide alkaloids and Ligustrum mannitol for the prevention and treatment of diabetic nephropathy has not been reported
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0063] This embodiment relates to a pharmaceutical composition for the treatment of type 2 diabetes, a pharmaceutical composition for the treatment of type 2 diabetes, comprising the following components in parts by weight: 3 parts of black plum, 5 parts of Chinese yam, 3 parts of Ganoderma lucidum 2 parts of reed root, 2 parts of Imperata rhizome, 2 parts of roasted licorice, 2 parts of Ophiopogon japonicus, 4 parts of Anemarrhena, 0.5 parts of Ligustrum mannitol, 2 parts of zinc sulfate, 2 parts of broiled astragalus, 5 parts of Polygonatum, Poria cocos 6 servings.
Embodiment 2
[0065] This embodiment relates to a pharmaceutical composition for treating type 2 diabetes. This embodiment relates to a pharmaceutical composition for treating type 2 diabetes, including the following components in parts by weight: 18 parts of black plum, 10 parts of Chinese yam 10 parts of Ganoderma lucidum, 18 parts of reed root, 18 parts of Imperata rhizome, 8 parts of roasted licorice, 9 parts of Ophiopogon japonicus, 15 parts of Anemarrhena, 3 parts of Ligustrum mannitol, 5 parts of zinc sulfate, 18 parts of broiled astragalus, sealwort 12 parts, Poria cocos 12 parts.
Embodiment 3
[0067] This embodiment relates to a pharmaceutical composition for treating type 2 diabetes. This embodiment relates to a pharmaceutical composition for treating type 2 diabetes, including the following components in parts by weight: 3 parts of black plum, 5 parts of Chinese yam 3 parts of Ganoderma lucidum, 2 parts of reed root, 2 parts of Imperata rhizome, 2 parts of roasted licorice, 2 parts of Ophiopogon japonicus, 4 parts of Anemarrhena, 0.5 parts of Ligustrum lucidum mannitol, 2 parts of zinc sulfate, 2 parts of roasted astragalus, sealwort 5 parts, Poria cocos 6 parts, triptolide 0.2 parts, triptolide alkaloid 1.2 parts.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a pharmaceutical composition for treating type 2 diabetes mellitus. The pharmaceutical composition comprises the following components in parts by weight: 3-18 parts of dark plum fruits, 5-10 parts of yam, 3-10 parts of ganoderma lucidum, 2-18 parts of reed rhizomes, 2-18 parts of lalang grass rhizomes, 2-8 parts of honey-fried licorice roots, 2-9 parts of dwarf lilyturf tubers, 4-15 parts of rhizoma anemarrhenae, 0.5-3 parts of glossy privet fruit mannitol, 2-5 parts of zinc sulfate, 2-18 parts of radix astragali preparata, 5-12 parts of rhizoma polygonati and 6-12 parts of poria cocos. The pharmaceutical composition has the beneficial effects that the pharmaceutical composition has significant adjuvant therapy effects on the type 2 diabetes mellitus and can stabilize the blood glucose of a patient, besides, the fasting blood-glucose efficiency and postprandial blood glucose efficiency change in a range of +/-5%, and the side effects are small.
Description
technical field [0001] The invention belongs to the technical field of natural medicines, in particular to a pharmaceutical composition for treating type 2 diabetes. Background technique [0002] Western medicine believes that diabetes is a chronic metabolic disease caused by genetic factors and environmental factors. Disorder, a disease that has a significant impact on the lives of patients. [0003] Diabetes is called diabetes in traditional Chinese medicine, and it is believed that it is due to congenital deficiency of limbs, weak viscera, addiction to fat, sweet, thick food, wine and cheese, accumulation of heat and tendons, long-term depression of emotions, heat and yin, excessive sexual labor, and loss of kidney essence , Sedentary and less active, physical weakness, disorderly taking warm and dry medicines and depleting yin and fluid caused by the disease. [0004] Currently, there is no cure for type Ⅰ and type Ⅱ diabetes. Therefore, the main methods of comprehens...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more